Addiction Today: PHARMACOLOGY AND ADDICTION

YOUR DEFINITIVE CUTTING-EDGE GUIDE

This article will be published on the website 30 June 2008

REFERENCES:

1. Addolorato G, Balducci G, Capristo E, Attilia ML, Taggi F, Gasbarrini G, Ceccanti M 1992: Gammahydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol Clin Exp Res. 23 1596-1604.

2. Addolorato G, Caputo F, Capristo E, Gasbarrini G 2001: Diazepam in the treatment of GHB dependence. Br J Psychiatry. 178 183.

3. Amraoui A, Burgos V, Baron P, Alexandre JY 1999: Acute delirium psychosis induced by naltrexone chlorhydrate. Presse Med. 28:(25) 1361-1362.

4. Bozart MA 1987: A Ventral Tegmental Reward System. In: Engel JO (Ed) Brain Reward System and Abuse. Raven Press, New York. pp1-17.

5. Bozart MA, Wise RA 1985: Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. In: Harris LS (Ed) Problems of drug dependence. NIDA, Washington, DC. pp190-196.

6. Daini L, Capone MR, Agueci T, Aglietti M, Zolesi O, Maremmani I 1995: Mood disorders in heroin dependence and clinical differences between heroin addicts whit and without mood disorders. In: Tagliamonte A, Maremmani I (Eds): Drug Addiction and Related Clinical Problems. Springer-Verlag, Vienna, New York. pp. 69-77.

7. Dole VP 1980: Addictive behaviour. Sci Am. 243 138-154.

8. Dole VP 1983: Addictive behaviour and the art of medicine. Subst Alcohol Actions Misuse. 4:(6) 445-453.

9. Dole VP, Nyswander ME 1967: Heroin Addiction: A Metabolic Disease. Arch Intern Med. 120 19-24.

10. Fadda F, Argiolas A, Melis MR, Serra G, Gessa GL 1980: Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra. Life Sci. 27 979-986.

11. Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu GP 1985: Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 348 201-203.

12. Goldstein A 1983: Some thoughts about endogenous opioids and addiction. Drug Alcohol Depend. 11 11-14.

13. Greenstein RA, Resnick RB, Resnick E 1984: Methadone and Naltrexone in the treatment of heroine dependence. Psychiatr Clin North Am 671-679.

14. Jenck F, Gratton A, Wise RA 1986: Opposite effects of ventral tegmental and periaqueductal gray morphine injections lateral hypotalamic stimulation-induced feeding. Brain Res. 399 24-32.

15. Koob GF 1992: Drugs of abuse: anatomy, pharmacology and function of reward patways. Trends Pharmacol Sci. 13 177-184.

16. Kornetsky C, Esposito RU 1979: Euphorigenic drugs: Effects on the reward pathways of the brain. Federation Proc. 38 2473-2476.

17. Kreek MJ, Koob GF 1998: Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51 23-47.

18. Kreek MJ, Zhon Y, Schussman S 2004: Craving in Opiate, Cocaine and Alcohol Addiction. Heroin Add & Rel Clin Probl. 6:(2-3) 5-52.

19. Maremmani I, Balestri C, Lamanna F, Tagliamonte A 1998: Efficacy of Split Doses of GHB Used as Anticraving in the Treatment of Alcohol Dependence. Preliminary Results. Alcoholism. 34 (1-2) 73-80.

20. Maremmani I, Lamanna F, Tagliamonte A 2001: GHB (Sodium Gamma-hydroxy-butyrate) long term therapy in treatment-resistant chronic alcoholics. J Psychoactive Drugs. 33:(2) 135-142.

21. Maremmani I, Marini G, Castrogiovanni P, Deltito J 1996: The effectiveness of the combination Fluoxetine-Naltrexone in Bulimia Nervosa. European Psychiatry. 11 322-324.

22. Maremmani I, Marini G, Fornai F 1998: Naltrexone induced Panic Attacks. Am J Psychiatry. 155:(3) 447.

23. Maremmani I, Pacini M, Giuntoli G, Lovrecic M, Perugi G 2004: Naltrexone as maintenance therapy for heroin addiction: Predictors of response. Heroin Add & Rel Clin Probl. 6:(1) 43-52.

24. Maremmani I, Raimondi F, Castrogiovanni P 1997: The GHB in the treatment of Alcoholism: from abstinance to craving. New Trends in Experimental and Clinical Psychiatry. XII:(3) 189-196.

25. Maremmani I, Zolesi O, Daini L, Castrogiovanni P 1999: Disturbi Correlati a Sostanze. Oppiacei. In: Cassano GB, Pancheri P, Pavan L, Pazzagli A, Ravizza L, Rossi R, Smeraldi E, Volterra V (Eds): Trattato Italiano di Psichiatria. Masson, Milano. pp1352-1377.

26. Martin WR 1972: Pathophysiology of narcotic addiction: possible role of protracted abstinence in relapse. In: Zarafonetis C D (Ed) Drug abuse. Lea and Febiger, Philadelphia. pp153-159.

27. Martin WR, Jasinski DR 1969: Physiological parameters of morphine dependence in man, early abstinence, protracted abstinence. J Psychiatr Res. 7 9-17.

28. McDaniel CH, Miotto KA 2001: Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. J Psychoactive Drugs. 33:(2) 143-149.

29. Measom MO 1996: Misuse of Naltrexone. J Clin Psychiatry. 57 488-489.

30. Spanagel R, Herz A, Shippenberg TS 1990: The effects of opioids peptides on dopamine release in the nucleus accumbens: an in-vivo microdialysis study. J Neurochem. 55 1734-1740.

31. Spanagel R, Herz A, Shippenberg TS 1990: Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur J Pharmacol. 190 177-184.

32. Stinus L, Cador M, Le Moal M 1992: Interaction between endogenous opioids and dopamine within the nucleus accumbens. In: Kalivas PW, Samson NH (Eds): The Neurobiology of Drug and Alcohol Addiction. Ann. N.Y. Academy of Science, New York. pp254-273.

33. Tagliamonte A, Maremmani I 2001: The problem of drug dependence. Heroin Add & Rel Clin Probl. 3:(2) 7-20.

34. Wise RA 1983: Brain Neuronal Systems Mediating Reward Processes, Biomedical Press, Amsterdam.

35. Wise RA 1989: The brain and reward. In: Liebman JM, Cooper SJ (Eds): The neuropharmacology of reward. Oxford University Press, Oxford. pp.

36. Wise RA 1990: The role of reward pathways in the development of drug dependence. In: Balfour DJK (Ed) Psychotropic drugs of abuse. Pergamon Press, Oxford. pp23-57.

37. Wise RA, Rompre PP 1989: Brain dopamine and reward. Annu Rev Psychol. 40 191-225.

38. Zuckin RS, Sugarman JR, Fitz-Syage ML, Gardner EL, Zuckin SR, Jintzler AR 1982: Naltrexone-induced opiate receptor supersensitivity. Brain Res. 245 285-292.